Logical Biological were delighted to exhibit for the first time at MEDICA, in Dusseldorf, Germany from 14 – 17 November 2022.

MEDICA – Leading International Trade Fair

MEDICA 2022 Infographic

MEDICA is one of the largest international events for the IVD Diagnostic industry and Logical Biological was one of over 5,000 exhibitors from over 70 countries . Logical Biological was pleased to see that visitor numbers were up from 2021 to more than 81,000 visitors, a significant increase from the 46,000 visitors that attended in 2021. In fact, MEDICA felt almost back to its pre-Covid self with the share of international visitors totalling 75 percent. European countries topped the visitor numbers, followed by South Korea and the USA. India and North African countries were also represented in large numbers. Many visitors noted that after the long pandemic break, they were happy to be able to talk to exhibitors again.

Logical Biological at MEDICA 2022

For Logical Biological, this was the first time exhibiting at MEDICA. Exhibiting gave us the opportunity to increase awareness within the industry of who Logical Biological are and how we can support and empower IVD manufacturers to develop high performance assays and associated calibrator and control material.

Thanks to some bold back-lit graphics we were a noticeable presence in the UK Gambica area of Hall 1, which enabled us to have many conversations with passing visitors, who we look forward to building working relationships with. Our team of three enjoyed over 30 pre-arranged meetings with customers and suppliers, and many more spontaneous ones. Better still, thanks to the support of Gambica we were able to have 2 meetings simultaneously by utilising the shared meeting area that Gambica offers.

MEDICA is always good way to get an overview of the market, to network and to see what the other companies are doing and where the trends are, this year was no exception. We look forward to attending more trade shows this year and further building the relationships we started at MEDICA.

 

Logical Biological Products

Logical Biological specialises in provision of human biospecimens, such as serum, plasma, swabs and saliva, all of which are essential components used in IVD tests, their development, calibration and quality control. 

Date of the next MEDICA in Düsseldorf: 13 –16 November 2023

Logical Biological is delighted to announce the appointment of Stephane Argivier as Non-Executive Director and Board member. Stephane has been involved in IVD and Life Science for the past 23 years, during most of which he has held leadership and executive positions, and built a successful track record of delivering fast and sustained growth with entities ranging from start-ups to multinationals.

Stephane is currently CEO and Board member of MIP Diagnostics, a rapidly growing company with a unique technology expanding the scope of affinity reagent applications & functionalities. Stephane was previously Managing Director at SCIPAC Ltd, a multi-business awards winning company, where he led a successful divestment of the company to the BBI Group on behalf of its shareholders. Stephane stayed with the organisation in various Executive roles for a further 9 years to enable a successful integration to what became BBI Solutions and to set-up a number of new business units, several of which have now reached a significant size. Stephane holds a Masters degree in Business and a degree in Applied Biology.

The appointment comes at a time when Logical Biological has established a strong market position as an ethical, quality focused and reliable source of best-in-industry human biological materials and is now preparing for the next stage of its journey. Dr James Steggles, Managing Director at Logical Biological said, “I am very pleased to welcome Stephane Argivier to the board of Logical Biological. Stephane’s experience in critical IVD reagents, especially within the clinical specimen market, will be extremely valuable as we continue to expand our business operations. We are delighted that Stephane will be joining our board and we look forward to working with him as we continue to build scale and success at Logical Biological”.

Stephane Argivier commented, “I am delighted to be joining Logical Biological at this pivotal time in its business cycle. I am truly impressed with the progress the company has made over the past few years and excited about its future.”

Logical Biological has gained ISO 9001:2015 certification. We have always operated a Quality Management System based on the ISO 9001 system, and now we have the certificate to prove we are fully ISO 9001 compliant. This emphasises our commitment to Quality processes and products.

Logical Biological specialises in provision of human biospecimens.

 

Our Managing Director James Steggles took time out at the recent AACC conference to join up with Sona Nanotech (experts in colloidal gold for Lateral Flow / Rapid Tests) to discuss human patient materials, reagents for IVD immunoassays and more! Tune in here:

 

Logical Biological has added Chagas antibody positive plasma to its range having received clearance from the UK government Health & Safety Executive to handle human biological material containing Trypanosoma cruzi, which is the causative agent of Chagas Disease. T. cruzi is a Hazard Group 3 pathogen according to “The Approved List of Biological Reagents”. Hazard Group 3 is defined as follows: “Can cause severe human disease and may be a serious hazard to employees; it may spread to the community, but there is usually effective prophylaxis or treatment available.”

As part of this process, the UK government has reviewed Logical Biological’s key risk assessments and standard operating procedures. Logical Biological has previously received clearance to handle human biological material infected with other Hazard Group 3 organisms such as HIV, Hepatitis B, Hepatitis C, Malaria (Plasmodium falciparum) and Tapeworm (Taenia solium).

You can see the full list of infectious disease materials offered by Logical Biological here.

Logical Biological has received clearance from the UK government Health & Safety Executive to handle human biological material containing Trypanosoma cruzi, which is the causative agent of Chagas Disease. T. cruzi is a Hazard Group 3 pathogen according to “The Approved List of Biological Reagents”. Hazard Group 3 is defined as follows: “Can cause severe human disease and may be a serious hazard to employees; it may spread to the community, but there is usually effective prophylaxis or treatment available.”

As part of this process, the UK government has reviewed Logical Biological’s key risk assessments and standard operating procedures. Logical Biological has previously received clearance to handle human biological material infected with other Hazard Group 3 organisms such as HIV, Hepatitis B, Hepatitis C, Malaria (Plasmodium falciparum) and Tapeworm (Taenia solium).

You can see the full list of infectious disease patient material offered by Logical Biological here. Please contact us for further information on any of our plasma/serum, antigen and monoclonal antibody products for IVD.